Logo image of SPRO

SPERO THERAPEUTICS INC (SPRO) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:SPRO - US84833T1034 - Common Stock

2.37 USD
-0.08 (-3.27%)
Last: 1/27/2026, 8:00:02 PM
2.37 USD
0 (0%)
Pre-Market: 1/28/2026, 6:55:39 AM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to SPRO. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 4.08. This target is 72.15% above the current price.
  • SPRO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about SPRO.
  • In the previous month the buy percentage consensus was at a similar level.
  • SPRO was analyzed by 6 analysts. More opinions would make the average more meaningful.
SPRO Historical Analyst RatingsSPRO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.374.044.084.084.20 - 70.46% 72.15% 72.15% 77.22%
SPRO Current Analyst RatingSPRO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-01-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-20 Evercore ISI Group Downgrade Outperform -> In-Line
2024-12-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-18 TD Cowen Downgrade Buy -> Hold
2024-11-15 Cantor Fitzgerald Reiterate Overweight
2024-11-04 HC Wainwright & Co. Maintains Buy -> Buy
2024-10-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-06 TD Cowen Upgrade Hold -> Buy
2024-08-06 Cantor Fitzgerald Reiterate Overweight
2024-08-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-04 Cantor Fitzgerald Reiterate Overweight
2024-03-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-14 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-10 HC Wainwright & Co. Reiterate Buy
2022-09-26 HC Wainwright & Co. Maintains Buy
2022-09-23 Evercore ISI Group Upgrade In-Line -> Outperform
2022-08-15 HC Wainwright & Co. Maintains Buy
2022-05-23 HC Wainwright & Co. Maintains Buy
2022-05-20 Berenberg Downgrade Buy -> Hold
2022-05-17 Cantor Fitzgerald Maintains Overweight
2022-05-04 Cowen & Co. Downgrade Outperform -> Market Perform
2022-05-04 Evercore ISI Group Downgrade Outperform -> In-Line
2022-04-18 HC Wainwright & Co. Maintains Buy
2021-10-01 Oppenheimer Downgrade Outperform -> Perform

SPERO THERAPEUTICS INC / SPRO FAQ

What is the average price target for SPERO THERAPEUTICS INC (SPRO) stock?

6 analysts have analysed SPRO and the average price target is 4.08 USD. This implies a price increase of 72.15% is expected in the next year compared to the current price of 2.37.


Can you provide the consensus rating for SPERO THERAPEUTICS INC stock?

The consensus rating for SPERO THERAPEUTICS INC (SPRO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.